Journal
JOURNAL OF ORTHOPAEDIC RESEARCH
Volume 28, Issue 11, Pages 1418-1424Publisher
WILEY
DOI: 10.1002/jor.21149
Keywords
titanium; inflammasome; neutrophils; IL-1; NALP3
Categories
Funding
- NIH [R01AI64349, P01AI083215-01]
- NIH/NIAID [U54AI057159]
- JDRF
- Diabetes Endocrinology Research Center [DK32520]
Ask authors/readers for more resources
Osteolysis of bone following total hip replacement is a major clinical problem. Examination of the areas surrounding failed implants has indicated an increase in the bone-resorption-inducing cytokine, interleukin 1 beta (IL-1 beta). NALP3, a NOD-like receptor protein located in the cytosol of macrophages, signals the cleavage of pro-IL-1 beta into its mature, secreted form, IL-1 beta. Here we showed that titanium particles stimulate the NALP3 inflammasome. We demonstrated that titanium induces IL-1 beta secretion from macrophages. This response depended on the expression of components of the NALP3 inflammasome, including NALP3, ASC, and Caspase-1. We also showed that titanium particles trigger the recruitment of neutrophils and that this acute inflammatory response depends on the expression of the IL-1 receptor and IL-1 alpha/beta. Moreover, administration of the IL-1 receptor antagonist (IL-1Ra) diminished neutrophil recruitment in response to titanium particles. Together, these results suggest that titanium particle-induced acute inflammation is due to activation of the NALP3 inflammasome, which leads to increased IL-1 beta secretion and IL-1-associated signaling, including neutrophil recruitment. Efficacy of IL-1Ra treatment introduces the potential for antagonist-based therapies for implant osteolysis. (C) 2010 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 28: 1418-1424, 2010
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available